UK Cancer Detection Firm CanSense Raises £1.5M for Development of Colorectal Cancer Test (360Dx) 0 By Praveen Suthrum on March 13, 2023 Exponential Tech Share Facebook Twitter LinkedIn Pinterest Email CanSense’s test is a blood-based assay that uses laser spectroscopy and artificial intelligence to identify early-stage colorectal cancer and precancerous polyps. Read More Artificial Intelligence Colorectal Cancer
User, expert and construct validation of a new colonoscopy simulator: correlation with National Endoscopy Database Key Performance Indicators (Science Direct)
Hackensack Meridian Jersey Shore University Medical Center Providing Novel Gastroenterology Treatments (Newswise)
Outlook Surgical Obtains FDA 510(k) Clearance for Hybrid Endoscope: A Breakthrough in Surgical Visualization (PR Newswire)
World’s First Fully Robotic Procedure by a Gastroenterologist Completed Using EndoQuest’s Endoluminal Surgical System in the PARADIGM Trial (GlobeNewswire)